UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

The role of FDG‐PET/CT in suspected recurrence of breast cancer

Cancer, 2006-12, Vol.107 (11), p.2545-2551

2006

Volltextzugriff (PDF)

Technetium‐99m‐MIBI SPECT/CT in Primary Hyperparathyroidism

World journal of surgery, 2006-01, Vol.30 (1), p.76-83

2006

Volltextzugriff (PDF)

Noninvasive diagnosis of solitary pulmonary lesions in cancer patients based on 2‐fluoro‐2‐deoxy‐D‐glucose avidity on positron emission tomography/computed tomography

Cancer, 2008-12, Vol.113 (11), p.3213-3221

2008

Volltextzugriff (PDF)

The role of FDG-PET/CT imaging in head and neck malignant conditions: Impact on diagnostic accuracy and patient care

Otolaryngology-head and neck surgery, 2007-07, Vol.137 (1), p.130-137

2007

Volltextzugriff (PDF)

Strikingly high false positivity of surveillance FDG‐PET/CT scanning among patients with diffuse large cell lymphoma in the rituximab era

American journal of hematology, 2013-05, Vol.88 (5), p.400-405

2013

Volltextzugriff (PDF)

Hodgkin lymphoma patients in first remission: routine positron emission tomography/computerized tomography imaging is not superior to clinical follow‐up for patients with no residual mass

British journal of haematology, 2014-03, Vol.164 (5), p.694-700

2014

Volltextzugriff (PDF)

Modification of initial therapy in early and advanced Hodgkin lymphoma, based on interim PET/CT is beneficial: a prospective multicentre trial of 355 patients

British journal of haematology, 2017-09, Vol.178 (5), p.709-718

2017

Volltextzugriff (PDF)

Risk-adapted BEACOPP regimen can reduce the cumulative dose of chemotherapy for standard and high-risk Hodgkin lymphoma with no impairment of outcome

Blood, 2007-02, Vol.109 (3), p.905-909

2007

Volltextzugriff (PDF)

MEK inhibitor treatment is effective in a patient with metastatic carcinoma of the ampulla of Vater with BRAF and NRAS mutations shown by next-generation sequencing

Anti-cancer drugs, 2016-07, Vol.27 (6), p.569-572

2016

Volltextzugriff (PDF)

FDG avidity and PET/CT patterns in primary gastric lymphoma

European Journal of Nuclear Medicine, 2008-08, Vol.35 (8), p.1424-1430

2008

Volltextzugriff (PDF)

FDG PET/CT for assessing the resectability of NSCLC patients with N2 disease after neoadjuvant therapy

Annals of nuclear medicine, 2016-02, Vol.30 (2), p.114-121

2016

Volltextzugriff (PDF)

The additional value of PET/CT over PET in FDG imaging of oesophageal cancer

European journal of nuclear medicine and molecular imaging, 2005-08, Vol.32 (8), p.918-924

2005

Volltextzugriff (PDF)

The value of FDG-PET/CT in assessing single pulmonary nodules in patients at high risk of lung cancer

European journal of nuclear medicine and molecular imaging, 2009-06, Vol.36 (6), p.997-1004

2009

Volltextzugriff (PDF)

A 10-year experience with treatment of high and standard risk Hodgkin disease: Six cycles of tailored BEACOPP, with interim scintigraphy, are effective and female fertility is preserved

American journal of hematology, 2012-01, Vol.87 (1), p.32-36

2012

Volltextzugriff (PDF)

Fluorodeoxyglucose-Positron Emission Tomography/Computed Tomography Imaging in Patients with Carcinoma of the Larynx: Diagnostic Accuracy and Impact on Clinical Management

The Laryngoscope, 2006-02, Vol.116 (2), p.273-278

2006

Volltextzugriff (PDF)

Fluorine-18 Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography Imaging in Patients With Carcinoma of the Nasopharynx: Diagnostic Accuracy and Impact on Clinical Management

International journal of radiation oncology, biology, physics, 2007-06, Vol.68 (2), p.370-376

2007

Volltextzugriff (PDF)

A functional dynamic scoring model to elucidate the significance of post-induction interim fluorine-18-fluorodeoxyglucose positron emission tomography findings in patients with Hodgkin’s lymphoma

Haematologica (Roma), 2010-07, Vol.95 (7), p.1198-1206

2010

Volltextzugriff (PDF)

FDG PET/CT differentiating two malignant tumors in the same patient

Acta oncologica, 2012-01, Vol.51 (1), p.142-144

2012

Volltextzugriff (PDF)

Physiologic Thymic Uptake of 18F-FDG in Children and Young Adults: A PET/CT Evaluation of Incidence, Patterns, and Relationship to Treatment

The Journal of nuclear medicine (1978), 2009-06, Vol.50 (6), p.849-853

2009

Volltextzugriff (PDF)

Assessing the use of FDG-PET in the detection of regional and metastatic nodes in alveolar rhabdomyosarcoma of extremities

Journal of pediatric hematology/oncology, 2006-07, Vol.28 (7), p.440-445

2006

Volltextzugriff (PDF)

Clinical Performance of PET/CT in Evaluation of Cancer: Additional Value for Diagnostic Imaging and Patient Management

The Journal of nuclear medicine (1978), 2003-08, Vol.44 (8), p.1200-1209

2003

Volltextzugriff (PDF)

Utility of Sonographically Guided Biopsy in Metabolically Suspected Recurrent Lymphoma

Journal of ultrasound in medicine, 2008-02, Vol.27 (2), p.225-231

2008

Volltextzugriff (PDF)

Clinical pretreatment risk factors and Ga‐67 scintigraphy early during treatment for prediction of outcome of patients with aggressive non‐Hodgkin lymphoma

Cancer, 2002-02, Vol.94 (4), p.873-878

2002

Volltextzugriff (PDF)

(18)F-FDG avidity in lymphoma readdressed: a study of 766 patients

The Journal of nuclear medicine (1978), 2010-01, Vol.51 (1), p.25-30

2010

Volltextzugriff (PDF)

PLASMA HEPARANASE AS A SIGNIFICANT MARKER OF TREATMENT RESPONSE IN CHILDREN WITH HODGKIN LYMPHOMA: Pilot Study

Pediatric hematology and oncology, 2009-01, Vol.26 (4), p.157-164

2009

Volltextzugriff (PDF)

1 – 25 von 61

Suche als RSS-Feed

Aktive Filter

ThemaFemale

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(60)
Mit Volltextzugriff
(52)

Publikationsform

Artikel
(61)

Sprache

Englisch
(61)

Erscheinungsjahr

n.n

Thema

Humans
(61)
Male
(50)
Adult
(46)
Life Sciences & Biomedicine
(44)
Science & Technology
(44)
Middle Aged
(40)
Aged
(35)
Adolescent
(26)
Biological And Medical Sciences
(23)
Medical Sciences
(22)
Aged, 80 And Over
(21)
Fluorodeoxyglucose F18
(21)
Radiopharmaceuticals
(20)
Sensitivity And Specificity
(19)
Oncology
(17)
Radiology, Nuclear Medicine & Medical Imaging
(17)
Positron-Emission Tomography - Methods
(16)
Tomography, X-Ray Computed
(16)
Child
(14)

14 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

The role of FDG‐PET/CT in suspected recurrence of breast cancer

Technetium‐99m‐MIBI SPECT/CT in Primary Hyperparathyroidism

Noninvasive diagnosis of solitary pulmonary lesions in cancer patients based on 2‐fluoro‐2‐deoxy‐D‐glucose avidity on positron emission tomography/computed tomography

The role of FDG-PET/CT imaging in head and neck malignant conditions: Impact on diagnostic accuracy and patient care

Strikingly high false positivity of surveillance FDG‐PET/CT scanning among patients with diffuse large cell lymphoma in the rituximab era

Hodgkin lymphoma patients in first remission: routine positron emission tomography/computerized tomography imaging is not superior to clinical follow‐up for patients with no residual mass

Modification of initial therapy in early and advanced Hodgkin lymphoma, based on interim PET/CT is beneficial: a prospective multicentre trial of 355 patients

Risk-adapted BEACOPP regimen can reduce the cumulative dose of chemotherapy for standard and high-risk Hodgkin lymphoma with no impairment of outcome

MEK inhibitor treatment is effective in a patient with metastatic carcinoma of the ampulla of Vater with BRAF and NRAS mutations shown by next-generation sequencing

FDG avidity and PET/CT patterns in primary gastric lymphoma

FDG PET/CT for assessing the resectability of NSCLC patients with N2 disease after neoadjuvant therapy

The additional value of PET/CT over PET in FDG imaging of oesophageal cancer

The value of FDG-PET/CT in assessing single pulmonary nodules in patients at high risk of lung cancer

A 10-year experience with treatment of high and standard risk Hodgkin disease: Six cycles of tailored BEACOPP, with interim scintigraphy, are effective and female fertility is preserved

Fluorodeoxyglucose-Positron Emission Tomography/Computed Tomography Imaging in Patients with Carcinoma of the Larynx: Diagnostic Accuracy and Impact on Clinical Management

Fluorine-18 Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography Imaging in Patients With Carcinoma of the Nasopharynx: Diagnostic Accuracy and Impact on Clinical Management

A functional dynamic scoring model to elucidate the significance of post-induction interim fluorine-18-fluorodeoxyglucose positron emission tomography findings in patients with Hodgkin’s lymphoma

FDG PET/CT differentiating two malignant tumors in the same patient

Physiologic Thymic Uptake of 18F-FDG in Children and Young Adults: A PET/CT Evaluation of Incidence, Patterns, and Relationship to Treatment

Assessing the use of FDG-PET in the detection of regional and metastatic nodes in alveolar rhabdomyosarcoma of extremities

Clinical Performance of PET/CT in Evaluation of Cancer: Additional Value for Diagnostic Imaging and Patient Management

Utility of Sonographically Guided Biopsy in Metabolically Suspected Recurrent Lymphoma

Clinical pretreatment risk factors and Ga‐67 scintigraphy early during treatment for prediction of outcome of patients with aggressive non‐Hodgkin lymphoma

(18)F-FDG avidity in lymphoma readdressed: a study of 766 patients

PLASMA HEPARANASE AS A SIGNIFICANT MARKER OF TREATMENT RESPONSE IN CHILDREN WITH HODGKIN LYMPHOMA: Pilot Study

Aktive Filter

Suchergebnisse filtern